Biblio
LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated β-catenin dephosphorylation in a subset of stem-like bladder cancer cells. BMC Med. 2024;22(1):19.
The impact of SBF2 on taxane-induced peripheral neuropathy. PLoS Genet. 2022;18(1):e1009968.